Newly discovered ovulation regulator holds promise for managing infertility

Cornell researchers have discovered a new cell signaling pathway involved in ovulation, a potential target for future research on infertility, contraception and ovarian disease.

Around Cornell

Treatment switch, liquid biopsy improve breast cancer outcomes

A clinical trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control.

Researchers map connections between the brain’s structure and function

Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports the way we think and act.

Biodegradable ‘heat bombs’ safely target specific cells

Cornell researchers developed a new way to safely heat up specific areas inside the body by using biodegradable polymers that contain tiny water pockets, a technology that could lead to precise and noninvasive diagnostics and therapeutics.

Research at risk: Better testing for tick-borne diseases

Unlike some current tests, new testing could provide results even before symptoms occur – and even for unknown diseases.

Cornell Atkinson awards catalyze solutions in food, climate, clean energy

Atkinson Venture Fund awards have distributed $21.7 million to 223 projects spanning every college on Cornell’s campus over 15 years.

Biodiversity allows for sustainable fisheries, better nutrition

To satisfy the seafood needs of billions of people, offering them access to a more biodiverse array of fish creates opportunities to mix-and-match species to obtain better nutrition from smaller portions of fish.

Research at risk: optimizing the US military’s nutritional ‘secret weapon’

A stop-work order imperils research that might enable U.S. active military members to benefit from better nutrition.

‘Stealthy’ lipid nanoparticles give mRNA vaccines a makeover

A new material developed at Cornell could significantly improve the delivery and effectiveness of mRNA vaccines – used to fight COVID-19 – by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.